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Recent advances in nanoparticulate biomimetic
catalysts for combating bacteria and biofilms
Xueqing Xiong,a Yanyan Huang,b Changxu Lin, a Xiang Yang Liu a,c and
Youhui Lin *a
Due to the abuse of antibiotics and the tendency of bacteria to form protective biofilms, the design
and development of new efficient agents that can eliminate bacteria and biofilms are still highly desired
but remain a great challenge; on the other hand, natural enzymes with unique catalytic characteristics
can cause an irreversible damage to the bacteria without inducing drug-resistance in the bacteria.
However, the intrinsic drawbacks, such as insufficient stability and high purification cost, of enzymes
significantly limit their antimicrobial applications. Therefore, significant research efforts have been
devoted towards the development of quality-equivalent or even superior enzyme substitutes with low
cost and high stability. In this regard, nanomaterials with extraordinary enzyme-mimetic catalytic activi-
ties (termed as nanozymes) are considered as suitable candidates. To date, nanozymes have been
proved to be promising materials for combating bacteria and biofilms under mild conditions. In this
review, we have summarized the recent progress of nanozymes in this highly active field. The antibac-
terial mechanisms of nanozymes and the roles of their sizes, morphologies, compositions, surface
modifications and microenvironment on their overall performance have been discussed. Moreover, the
current challenges and prospects in this research area have been discussed. We believe that nanozymes
with unique features and functions can provide a wealth of opportunities via their clinical and industrial
applications.
Bacterial infection, one of the primary causes of morbidity
and death, is a global problem that humankind must solve. To
date, antibiotics have been widely and frequently used for the
treatment and prevention of these infections. However, the
abuse of antibiotics has prompted the emergence of drug-
resistant bacteria such as methicillin-resistant Staphylococcus
aureus (S. aureus). Bacteria can adapt or become resistant to
antibiotics via a variety of ways such as by inactivating the
enzyme, decreasing the cell permeability, changing the target
site, and increasing the efflux;1 therefore, due to the increas-
ingly serious antibiotic resistance of pathogenic bacteria, it
has become difficult to combat them.1 Moreover, biofilm is a
community of bacteria with close communication in a matrix
of extracellular polymeric substances (EPS). In addition, bio-
films can hold the bacteria together and form recalcitrance to
treatment by antibacterial agents;1 therefore, the design and
development of new and efficient antimicrobial agents is still a
key challenge. Recent advances in nanoscience and nano-
technologies have provided opportunities for the use of nano-
materials as components towards the development of antibac-
terial and antibiofilm agents: (1) nanostructured materials can
be used as nanocarriers to achieve efficient delivery of antimi-
crobials or drugs;2–4 (2) many nanomaterials themselves
possess intrinsic antibacterial and antibiofilm activities;5,6 and
(3) due to the intrinsic antibacterial potential or other special
properties of nanomaterials, their presence can help the for-
mation of synergistic systems that combine two or more anti-
microbial agents or the construction of smart on-demand
therapeutic modalities.7,8 To date, many nanomaterials with
antibacterial activities have been well investigated to kill
bacteria.1,7–11 The widely explored Ag nanoparticles, for
example, have been reported to have good antibacterial
activity, which is mainly because of the release of Ag+ that trig-
gers the production of intracellular reactive oxygen species
(ROS) and thus causes the lysis of a broad spectrum of bac-
teria;12 although these nanoparticles are promising, their
inherent cytotoxicity limits their development.12 In addition,
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some photocatalysts can serve as antibacterial agents by
photo-catalytically causing oxygen reduction and generating
reactive oxygen species such as •O2− and H2O2.
13,14 Recently,
nanomaterials with enzyme-like activities have also been dis-
covered to combat bacteria and biofilms. These catalytically
active nanomaterials are also termed as nanozymes.1 The use
of nanozymes as antimicrobial agents takes inspiration from
nature.
In living systems, some natural self-defense systems exist
that utilize biocatalysts to irreversibly damage the bacteria or
disrupt the biofilm integrity. For example, peroxidase and
oxidase in lysosomes can catalyze the generation of ROS to
combat bacterial invasion. However, natural enzymes often
suffer from inherent shortcomings such as high cost and poor
stability. Recently, tremendous efforts have been devoted
towards the construction of nanozymes15–19 including metal-,
metal oxide-, sulfide metal-based nanomaterials,20–23 carbon-
based nanomaterials,24 and nano-hybrids.25,26 Compared with
natural enzymes, nanozymes are cost-effective and more sus-
tainable. Moreover, these nanoparticulate biomimetic catalysts
as antimicrobial agents show good biocompatibility under the
dosage needed to achieve an effective clinical outcome, special
chemical and physical properties (e.g., optical, electronic, and
magnetic properties), tunable surface properties, and ease of
functionalization for enhancing the antibacterial efficiency.
These unique properties may offer a possibility for the develop-
ment of novel multifunctional antimicrobials. Recently, the
utilization of nanozymes in fighting multi-drug resistant bac-
teria and biofilms has become a hot research area.27–29
Although many excellent studies have been reported in this
regard, to the best of our knowledge, no comprehensive review
has been devoted towards the current progress. Herein, this
review provides an update on the recent developments of these
nanoparticulate biomimetic catalysts in combating bacteria
and biofilms. The antibacterial mechanisms and the roles of
their sizes, morphologies, compositions, surface modifi-
cations, and microenvironment on their overall performance
have also discussed in this review (Scheme 1). Furthermore,
the current challenges and prospects of nanozymes in this
area have been discussed. We hope that the introduction of
nanozymes can broaden the research fields of combating bac-
teria and biofilms and enlarge the range of new possibilities
for catalytically active nanomaterials.
The antibacterial mechanisms of
nanozymes
To date, many nanozymes have been discovered to possess
intrinsic antibacterial and antibiofilm activities (Table 1).
Although the mechanisms of these unexpected activities have
not been thoroughly studied and fully understood, they mainly
involve the following three aspects:
(1) The generation of highly active ROS products by redox
nanozymes. Most of the antibacterial activities of nanozymes
originate from their ability to modulate the level of ROS such
as hydroxyl radical (•OH) and superoxide anion (O2
•−).30 Owing
to their high oxidation capability, ROS can attack bacteria and
biofilms and unselectively defunctionalize many biomolecules
such as lipids, proteins and nucleic acids, leading to the dis-
ruption of the bacterial cytoplasmic membrane, DNA damage,
and protein deactivation. Moreover, it is difficult for the bac-
teria to develop resistance to these antimicrobials as they
cause membrane destruction; therefore, by increasing the
level of ROS, the bacteria may be quickly and efficiently
killed.14,31,32
As is known, H2O2 alone can serve as a common antibac-
terial agent. To achieve good antibacterial performance, a
relatively higher concentration of H2O2 (0.5–3%) is often
needed.33 However, healthy tissues may also be affected when
exposed to this high level of H2O2.
32,33 Fortunately, the pres-
ence of peroxidase-like nanozymes can decompose H2O2 into
the highly oxidative •OH.33,34 In this way, a much lower con-
centration of H2O2 is needed to achieve higher antibacterial
efficacy, which is more friendly to the organism. We observed
that the formation of •OH by peroxidase-like nanozymes
might depend on their types. For gold nanoparticle-based
peroxidase mimics, H2O2 can be adsorbed on the surface of
gold nanomaterials, and then, the O–O bond of H2O2 may be
broken into double hydroxyl radicals.35 In addition, nano-
materials with oxidase-like activity can modulate the level of
ROS by catalytically producing •O2
− from oxygen. In this way,
the supply of H2O2 is no longer necessary to exert antibacter-
ial effects.36
(2) The cleavage of extracellular DNA (eDNA) by hydrolytic
nanozymes. eDNA is one of important EPS constituents for
many bacterial species and has a very significant role in main-
taining the biofilm integrity.16,37 Deoxyribonuclease (DNase)
mimics can cleave eDNA to inhibit the formation of biofilms
and disperse the established biofilms.
(3) The interference of quorum sensing by haloperoxidase
mimics. Haloperoxidase mimics that can quench auto-indu-
cers (small molecules related to quorum sensing) have been
reported to successfully prevent biofilm growth and disrupt
biofilms.38
Scheme 1 Schematic of the biofilm formation model and nanoparticu-
late biomimetic catalysts for combating bacteria and biofilms.
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A single antibacterial system based on
nanozymes
The ongoing accumulation and continuous innovation of
nanozyme systems have enabled the nanozymes to control the
bacterial infection. As catalysts, the activities of nanozymes are
affected by many factors such as their sizes, morphologies,
compositions, surface modification and microenvironment.
Thus, an enhancement in the activity of nanozymes may lead
to better antimicrobial performance.
Based on the important influence of size on the activity of
nanozymes as well as the better penetration of ultrasmall-sized
nanozymes into bacterial cells, Wang et al. have demonstrated
that ultrasmall mercaptopyrimidine-conjugated gold nano-
clusters exhibit excellent oxidase- and peroxidase-like activities
and induce the generation of intracellular ROS after their
entry. Compared with 6 nm gold nanoparticles, the obtained
gold nanoclusters possessed significantly higher antibacterial
activity. Especially, 4,6-diamino-2-mercaptopyrimidine-conju-
gated Au NCs (AuDAMP) exhibited superior antibacterial
effects on both Gram-positive and Gram-negative bacteria than
other mercaptopyrimidine-conjugated Au NCs. As illustrated
in Fig. 1, the highly positively charged AuDAMP could electro-
statically adsorb on the surface of the bacteria and destruct
the cell membrane; this led to its efficient internalization. In
this way, AuDAMP with oxidase- and peroxidase-like activities
could induce a dramatic increase in the intracellular ROS level,
accelerating the death of bacteria. A mouse skin infection
model was further designed to value their potential biological
application. Moreover, the experimental data demonstrated
wound healing and 99% antibacterial efficacy with treatment
using AuDAMP (0.1 mL, 10 μg mL−1) after 10 days.23 Moreover,
a recent study has reported that single-atom nanozymes, ZIF-8-
derived carbon nanomaterials, within which unsaturated Zn–
N4 sites have been atomically dispersed, has a high peroxi-
dase-like activity to catalytically decompose H2O2 into
•OH.
The generated •OH exerted outstanding property of attacking
the bacteria. This enzyme-like catalytic activity might be attrib-
uted to the unsaturated Zn–N4 active sites in these single atom
nanozymes where H2O2 was absorbed, activated and then
decomposed. In the presence of the single-atom nanozymes
and a low dosage of H2O2 (100 μM), up to 99.87% of
P. aeruginosa growth could be prevented. Moreover, the wound
Table 1 Enzyme-mimetic nanoparticles against pathogens
Types of nanoparticles Enzyme-mimetic activities Antibacterial mechanisms Targets
Single atom nanzozyme39 Peroxidase-like activity Generation of •OH P. aeruginosa
o-CNTs40 Peroxidase-like activity Generation of •OH S. aureus, E. coli
Modified CuO nanorods41 Peroxidase-like activity Generation of •OH E. coli
Graphene quantum dots38 Peroxidase-like activity Generation of •OH S. aureus, E. coli
AuDAMP23 Peroxidase- and oxidase-like activity Generation of •OH and •O2
− E. coli, A. baumannii,
P. aeruginosa, MRSA,
MDR K. pneumoniae, VRE
Pt hollow nanodendrites42 Peroxidase- and oxidase-like activity Generation of •OH and •O2
− S. aureus, E. coli
GQD/AgNP hybrids36 Peroxidase- and oxidase-like activity Generation of •OH and •O2
− S. aureus, E. coli
Mesoporous Silica-Supported
gold Nanoparticles38
Peroxidase- and oxidase-like activity Generation of •OH and •O2
− S. aureus, E. coli
Porous Pt/Ag nanoparticles38 Peroxidase- and oxidase-like activity Generation of •OH and •O2
− S. aureus, E. coli
PEG-MoS2 nanoflowers
32 Peroxidase-like activity Combination of the generation
of •OH and photothermal therapy
E. coli, B. subtilis
CaO2/H-G@alginate
43 Peroxidase-like activity Generation of •OH in cascade
reaction
S. aureus, E. coli
IOPs44 Peroxidase-like activity Combination of the generation of
•OH and the antibiotic methicillin
Biofilms




46 DNase- and peroxidase-like activity Multivalent CeIV center for hydro-
lyzing eDNA, generation of •OH
Biofilms
V2O5 nanowires
38 Haloperoxidase-like activity Generation of HOBr for the
bromination of the signal molecules
Biofilms
CeO2−x nanorod
47 Haloperoxidase-like activity Generation of HOBr for the
bromination of the signal molecules
Biofilms
Fig. 1 Schematic of Au NCs as an antibacterial agent with oxidase- and
peroxidase-like catalytic properties. Reprinted with permission from ref.
23. Copyright ACS 2018.
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infection model further illustrated that with the assistance of
the nanozymes and H2O2, the wound could completely heal
after 6 days. This study contributed to the advancement of
single-atom catalysts for biological applications.39
Modulation of the morphology can change the contact area
with the substrates and the utilization of active sites, which is
bound to dramatically impact the activity. Using various syn-
thesis methods, nanomaterials with numerous morphologies,
including rod, sheet, cage, and needle, have been developed.
For example, Ge et al. have synthesized Pt hollow nanoden-
drites through chemical deposition and etching. They have
reported that the obtained hollow nanodendrites can exhibit
higher peroxidase-like activity than the Pd@Pt core-frame
nanodendrites. This might be due to the high-index facets of
the Pt branches and more exposure of the active sites.
Moreover, the Pt hollow nanodendrites possessed oxidase-like
activity, which was further beneficial to achieve higher antibac-
terial property. In the presence of 10 μM H2O2, the Pt hollow
nanodendrites could kill S. aureus and Escherichia coli (E. coli)
with the general lethality of 71.9%. Moreover, the experimental
data of the mouse model showed that a bio-safe dosage of the
nanozyme with relatively low concentration of H2O2 could
work well in wound disinfection.42
More interestingly, metal- or inorganic-based nanohybrids
have also attracted researchers’ attention because the inter-
action between different components can offer the possibility
of creating novel or superior properties. Recently, Chen and co-
workers have successfully designed a graphene quantum dot/
Ag nanoparticle (GQD/AgNP). Due to the synergistic effect
between different components, the hybrids could exhibit not
only an enhanced oxidase-like activity arising from the AgNPs,
but also a higher peroxidase-like activity due to the faster elec-
tron transfer and reduction of –C–OH on the GQD. When bac-
teria were treated with GQD/AgNP hybrids (2 μg mL−1), only
33% of S. aureus and 18% of drug-resistant E. coli survived. On
the contrary, the commercial antibiotics ampicillin and amoxi-
cillin showed little antibacterial efficacy even at the concen-
tration of 100 μg mL−1. Further studies have demonstrated
that with the addition of H2O2 or the introduction of photo-
dynamic therapy, the antibacterial efficacy would be enhanced;
based on these observations, it has been confirmed that nano-
hybrids can efficiently generate ROS and thus exhibit excellent
antibacterial activity against bacteria.36
In addition to the regulation of size, morphology, and com-
positions as abovementioned, surface modification, microenvi-
ronment adjustment,16 and application of external power41 are
feasible strategies to improve the antibacterial effects of nano-
zymes. To date, surface modification has been widely applied
to endow multiple functions and improve the properties of
nanozymes. For example, some polymers, such as chitosan,
can act as stabilizers of AgNPs to prevent their aggregation and
improve their stability.48 In addition, biotics, such as vancomy-
cin, can be coupled to some metal nanoparticles for targeting
a wide range of bacteria.49 These surface modification
methods would be beneficial for the performance of antibac-
terial agents. For example, since the carbonyl groups on
carbon nanotubes are active sites for their peroxidase-like
activity, whereas the carboxyl groups and hydroxyl groups are
the competitive sites, the oxygen-group-enriched carbon nano-
tubes (o-CNTs) can be modified to have higher peroxidase-
mimetic activity by blocking the carboxyl groups. The modified
o-CNTs were proved to demonstrate improved antibacterial
effects when employed in disinfection.40 External power, such
as light, can also be a tool to modulate the enzyme-like activi-
ties of some nanoparticles.50 CuO nanorods (CuO NRs),
designed to possess appropriate energy-band structures, were
reported to show enhanced peroxidase-like activity when
exposed to visible light. In this study, the synthesized p-type
semiconducting CuO NRs had typical narrow band gaps that
allowed the nanorods to absorb visible light. When they were
activated under light illumination, their affinity to H2O2 was
over 4 times that of the unilluminated nanorods, resulting in
20 times enhancement in the •OH production rate (Fig. 2A). As
shown in Fig. 2B, under light illumination, more •OH species
were generated when compared with the case of the dark con-
dition, causing severe damage to bacteria with the same
dosage of H2O2.
41 This light-tuning-activity method might
introduce a highly attractive way to trigger on-demand antibac-
terial function.
Moreover, a recent report showed that the presence of histi-
dine on the surface of Fe3O4 nanoparticles could enhance the
intrinsic peroxidase-like activity of Fe3O4 nanoparticles. With
the assistance of histidine, H2O2 could be accurately located in
the active site cavity. It was proved that with similar size or
morphology, histidine-modified Fe3O4 nanoparticles had a
better affinity towards the substrates and higher peroxidase-
like activity than naked-Fe3O4.
51 The key of this method was to
use biocompatible alternatives to mimic the structures of
Fig. 2 Antibacterial performance of the CuO NRs under visible light
illumination. (A) Schematic of antibacterial efficacy based on the
enzyme-like activity of CuO NRs; (B) representative TEM images of
E. coli after different treatments: (a) untreated; (b) CuO NRs + H2O2 in
the dark; (c) CuO NRs + H2O2 with visible light illumination. Reprinted
with permission from ref. 41. Copyright ACS 2018.
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natural enzymes for enhancing the catalytic performance.51,52
Inspired by this study, Wang et al. used poly (2-acrylamido-2-
methyl-1-propane sulfonic acid)-based hydrogels to act as good
carriers and offer Fe3O4 nanoparticles with better affinity to
the substrates. By modulating the crosslinking concentration
of the hydrogels, the affinity to H2O2 could be adjusted such
that the peroxidase-mimetic activity of the Fe3O4 component
was improved.53 Overall, it is conceivable that by providing an
appropriate microenvironment, the catalytic activity, such as
oxidase- and peroxidase-like activity, of nanozymes can be
greatly improved, leading to enhanced antibacterial performance.
A synergetic antibacterial system
based on nanozymes
Nanozyme-based synergetic systems can also be applied for
increasing the antibacterial efficiency and selectivity.38 The use
of sterilizing molecules, photothermal treatment and anti-
biotic delivery are promising strategies in this regard.9,54,55 It
is well established that organosulfur compounds, such as
allicin, are main contributors to the antibacterial performance
of garlic bulbs. However, for a single kind of organosulfur
compounds, the instability and relatively poorer antibacterial
effects limit their potential biomedical applications. To this
end, recent studies have started to explore the possibility of
nanoscale metal sulfides as antibacterial agents. Among them,
nano-scale iron sulfides (nFeS) converted from organosulfur
compounds (e.g., cysteine, DADS, or DATS) have attracted
researchers’ attention. It was found that cysteine0.5-nFeS, in
which 0.5 g of cysteine was added in a total volume of 50 mL
of the solvothermal system, could exhibit superior antibacter-
ial efficacy and broader antibacterial performance. Their anti-
bacterial effects can be several hundred times higher than
those of garlic-derived organosulfurs; further studies have
indicated that hydrogen disulfane and hydrogen trisulfane,
which are released from the oxidative and nanostructural
transformations on nFeS (Fig. 3A and B), respectively, are
mainly responsible for the antibacterial efficacy of nFeS; this
result is based on the fact that H2S2 and H2S3 can kill bacteria
and disrupt the biofilm integrity efficiently. Moreover, H2O2
decomposition, catalyzed by the intrinsic peroxidase-like
activity, could promote the oxidation of nFeS to accelerate the
polysulfane release as well as increase the bacteria-killing
efficacy of H2O2. The correlation of free sulfide release and the
H2O2 concentration reflected from OD340 nm (the absorbance
at 340 nm that characterized free sulfide in the supernatant) in
Fig. 3C further verified this conclusion. Wound healing in
animal experiments also indicated the great potential of poly-
sulfanes to combat bacteria and biofilms through the synergis-
tic effect of the enzyme-like activity and catalysis-accelerated
release of polysulfanes (Fig. 3D).56
Photothermal therapy is an attractive strategy that has
recently been explored to be incorporated into nanozyme
systems for antibacterial applications. During this therapy,
abundant heat can be generated by the photo-absorbing
agents under near-infrared (NIR) irradiation.57 A previous
study has proved that molybdenum disulfide (MoS2) nano-
materials possess excellent peroxidase-like activity and high
efficiency of NIR photothermal conversion. Inspired by these
unique properties, Zhao, Gu, and coworkers have constructed
polyethylene glycol-functionalized molybdenum disulfide
nanoflowers (PEG-MoS2 NFs) for antibacterial applications
(Fig. 4A). The experimental data showed the concentration-
dependent and NIR irradiation-promoted antibacterial per-
formance of the PEG-MoS2 NFs. As shown in Fig. 4B, a dra-
matic decrease in the bacterial viability was observed with an
increase in the concentration of PEG-MoS2 NFs. Moreover,
under 808 nm NIR irradiation, the bacterial viability declined
significantly. By combining the peroxidase-like capacity and
photothermal property, the obtained PEG-MoS2 NFs achieved
almost 100% sterilization rate. The wrinkled morphology of
the bacteria shown in the SEM images further proved the
severe damage caused by the treatment of MoS2–H2O2 with
NIR irradiation (Fig. 4C).32
Although ROS is deadly to bacteria, the premise is that
ROS efficiently acts on the targeted bacteria. In this way, accu-
rate and controllable delivery becomes a vital point that
needs careful consideration. To solve this problem, the intro-
duction of the targeting effect can be a practical way.4
Recently, Qu, Ren, and coworkers successfully designed a
novel nanocomposite, where prodrug ascorbic acids were
encapsulated in hyaluronic acid-dopamine conjugate-deco-
Fig. 3 The antibacterial activity of nFeS based on polysulfane release.
(A) Schematic showing the polysulfane release from nFeS. (B) The ratio
of different kinds of polysulfanes in the supernatant by LC–MS/MS. (C)
Increase in polysulfane release driven by H2O2 via catalysis. (D)
Sterilization and infected-wound healing using the nFeS regimen.
Reprinted with permission from ref. 56. Copyright 2018 Nature
Publishing Group.
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rated graphene-mesoporous silica nanosheets. Vancomycin-
modified ferromagnetic nanoparticles were then carried on
them. As is well-known, vancomycin is a kind of antibiotics
that can bind specifically to the amino acid residues of the
glycanpeptidyl precursor on the bacterial cell wall to interfere
with peptidoglycan synthesis, finally damaging and killing the
bacteria.58 Therefore, once vancomycin guided the nanoagents
to the bacterial surface, the degradation of the hyaluronic acid–
dopamine conjugates caused by bacteria could promote the
release of ascorbic acids. In addition, ferromagnetic nano-
particles could catalytically induce ROS generation near the bac-
teria. Moreover, the excellent photothermal property of gra-
phene further contributed to the sterilizing effects.34
Traditional nanozyme-based antibacterial systems require
the supply of H2O2. However, a recent study has claimed that
to realize great antibacterial efficacy, the additional adminis-
tration of H2O2 is not necessary. In a system where CaO2 and
hemin-loaded graphene were integrated into alginate (CaO2/
H-G@alginate), CaO2 could react with water to self-generate
H2O2, which was, in turn, transformed into highly toxic
•OH
with the assistance of hemin-loaded graphene. The results
obtained after coincubating CaO2/H-G@alginate with Gram-
positive S. aureus and Gram-negative E. coli well evaluated the
great germicidal activity of this system. The survival of
S. aureus and E. coli decreased to 9.1% and 4.6%, respectively.
Moreover, it was proved in the in vivo biofilm model that CaO2/
H-G@alginate could inhibit biofilm formation and destruct
the biofilms, causing over 90% reduction of biomass after
treatment for 24 h.43 This nanozyme-based cascade system
might open a new avenue for preventing bacterial infection in
the absence of H2O2.
Nanozymes for combating biofilms
A biofilm, as a community where multiple microbial cells live
in a complex matrix EPS, consists of many components such
as proteins, polysaccharides, nucleic acids and other bio-
molecules.59 The formation of a biofilm may involve three
stages: the attachment of bacteria to the surface of the sub-
strates for initial colony formation, the microcolony formation,
and differentiation into a mature biofilm. Notably, some
necessary quorum sensing molecules are responsible for regu-
lating the growth of biofilms.59–61 Biofilms are inherently recal-
citrant to antimicrobials. On the one hand, it could be due to
the failure of these antimicrobials to penetrate into the matrix.
On the other hand, it has also been reported that intercellular
communication can induce the quick response of microbes
and regulate metabolism. Through this progress, microbes
could adapt to the new environment quickly with improved re-
sistance.62 The formation of a biofilm provides a significant
challenge to the sterilization and infection treatments.
Therefore, it is urgent to develop novel and highly efficient
agents for combating biofilms.
ROS, as strong oxidants, can destroy biofilms by destroying
the important components and bacteria in the biofilm matrix.
However, as the bacteria in biofilms are closely connected, ROS
catalytically induced by nanozymes should have the capability of
thoroughly destroying the entire biofilm such that biofilms do
not regenerate. Moreover, good binding ability and activity reten-
tion within the biofilm are highly beneficial to the disruption of
biofilms. To achieve this goal, catalytic nanoparticles containing
Fe3O4 (CAT-NPs) were successfully constructed by the Koo’s
group. The CAT-NPs were able to well retain their peroxidase-like
activities throughout the S. mutans biofilms and could penetrate
the biofilms in depths ranging from 25 to 150 μm.
Consequently, the generation of ROS in situ could realize the
efficient disruption of the S. mutans biofilm, inhibiting the
development of caries efficiently.62 Similarly, ferumoxytol nano-
particles with peroxidase-like capacity were also found to be able
to disrupt intractable biofilms and prevent dental caries.63
Interestingly, this biocompatible nanomaterial with antibiotics
together can be loaded into nanocarriers to realize cooperation
in combating the biofilms. Polymersomes have been shown to
co-encapsulate hydrophobic superparamagnetic iron oxide nano-
particles (SPIONs) and the hydrophilic antibiotic methicillin for
the treatment of caries. Under an external magnetic field, the
iron oxide-encapsulating polymersomes (IOPs) could penetrate
deeper in the biofilms, promoting the delivery of the antibiotics.
Thus, the IOPs were able to generate ROS via the encapsulated
nanozymes and released antibiotics in a 20 μm thick
Staphylococcus epidermidis biofilm (Fig. 5A). Confocal laser scan-
ning microscopy analysis results shown in Fig. 5B demonstrated
that 40 μg mL−1 SPION and 20 μg mL−1 of methicillin containing
IOPs could achieve complete eradication of methicillin-resistant
S. epidermidis biofilms, the main cause of dental caries.44
In addition to the oxidoreductase mimics for combating
the biofilms, nanomaterials with hydrolase-like property can
also serve as antibiofilm agents. In the growth process of bio-
Fig. 4 Antibacterial performance of the PEG-MoS2 NFs. (A) Schematic
of the killing of bacteria by PEG-MoS2 via a combination of peroxidase-
like activity and photothermal treatment. (i) Bacteria were absorbed on
PEG-MoS2; (ii) PEG-MoS2 catalyzed the formation of
•OH from the
decomposition of a minimal amount H2O2 to damage the cell mem-
brane integrity; (iii) PEG-MoS2 released abundant heat under irradiation
with a 808 nm laser, thus accelerating GSH oxidation. (B) The survival
rate of Ampr E. coli after treatment with various concentrations of
PEG-MoS2 NFs with or without H2O2 when exposed to the 808 nm
laser. (C) FE-SEM images of Ampr E. coli after different treatments. (a)
PBS, (b) H2O2, (c) MoS2, (d) MoS2 + NIR, (e) MoS2 + H2O2, and (f ) MoS2 +
H2O2 + NIR. Irradiation time: 10 min. Reprinted with permission from
ref. 32. Copyright ACS 2016.
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films, eDNA plays a significant role in the interaction between
the cells and their adhesion to the surface. Also, it is closely
related to the formation of structural stability, the guidance of
bacterial motility, and the resistance to antibiotics.64,65
Accordingly, eliminating eDNA is likely to be a promising
method for disrupting the biofilm. DNase is a kind of enzyme
capable of disposing off eDNA.66 However, the limited pene-
trating ability and operational stability impede its further
application. It is well known that Ce(IV)-containing biocatalysts
can serve as DNase mimics to hydrolyze DNA or RNA. Qu and
colleagues successfully synthesized DNase-mimetic artificial
enzyme (DMAE) by assembling cerium(IV) ion complexes on
the Au component of the Fe3O4/SiO2 core/shell nanoparticles.
The obtained DMAE showed efficient penetration and exhibi-
ted outstanding DNase-like property. It could induce the clea-
vage of 80% eDNA inside the biofilms and prevented over 90%
of bacterial adhesion. Furthermore, DMAE was able to degrade
eDNA in the established biofilms, consequently damaging the
integrity of the established biofilms, which natural DNase
could not match.45 A recent study indicated that the marriage
of two kinds of nanozymes could achieve complete biofilm
elimination and the prevention of secondary biofilm for-
mation. In this study, Au-doped MIL-88B (Fe) (named as
MOF−Au) was first prepared to exert peroxidase-like activity. On
adjusting the dosage of Au to 2.5 μmol, the obtained
MOF−2.5Au could achieve the highest peroxidase-like activity.
Ce complexes were then modified on the surface of the pre-
pared MOF−2.5Au to provide DNase-like activity. In this way, the
obtained MOF−2.5Au–Ce could possess both peroxidase- and
DNase-like activity. The antibacterial treatment and mouse
wound model demonstrated that MOF−2.5Au–Ce alone could
only disperse the biofilms, while the combined system of both
MOF−2.5Au–Ce–H2O2 could destroy most of the biofilms.
Compared with the MOF−2.5Au/H2O2 mixture system,
MOF−2.5Au–Ce–H2O2 caused more severe loss of biomass. These
outcomes confirmed the idea that the integrated nanozymes
(MOF−2.5Au–Ce) were able to disperse the biofilms via DNase-
mimic activity and simultaneously killed the exposed bacteria
by ROS.46 This work can provide a creative way to enhance the
anti-biofilm efficacy by a nanozyme-based synergistic system.
Furthermore, nanomaterials with haloperoxidase-like
activity could also be used for anti-biofilm activity through
interfering quorum sensing. Quorum sensing is a cell-to-cell
communication process that helps a bacterial community to
regulate the gene expression in response to cell density
changes. Bacteria exchange information through quorum
sensing, thus eliciting a series of physiological activities to
build an advanced organism. Quorum sensing relies highly on
chemical signal molecules, namely, autoinducers, which
deliver information on the cell density changes. Quenching
these signaling compounds can seriously interfere with
quorum sensing, which consequently inhibits the formation of
biofilm. Haloperoxidase has been proved to have the ability to
catalyze the synthesis of antagonists against the autoinducers
to disrupt QS.67,68 Inspired by this, Tremel et al. discovered
that CeO2−x nanorods exhibited intrinsic haloperoxidase-like
capacity and could be used for combating biofilms. In the
presence of Br− and H2O2, the CeO2−x nanorods could catalyze
the production of HOBr. The generated HOBr was destructive
for the biofilms. They interpreted that the CeO2−x nanorods
containing both tri- and tetravalent states of cerium could
form a polycrystalline construction. This mixed-valence state
might contribute to rapid redox cycles, which correlated
closely with the catalytic activity. To verify the potential appli-
cation of the CeO2−x nanorods, a plate coated with a CeO2−x
nanorod-containing paint was designed. The control experi-
ment demonstrated that the CeO2−x-treated plate showed little
indication of biofouling.47 Similarly, CeO2−x nanorods could
be used in nanofibers to prevent biofilm formation. A study
showed that electrospun PVA mats containing the CeO2−x
nanorods showed haloperoxidase-like activity and high anti-
biofouling properties.69
Summary and outlook
In this review, we summarized the recent progress of nano-
zymes for antibacterial/antibiofilm applications. The catalytic
Fig. 5 Antibacterial efficiency of IOPs. (A) Schematic of biofilm disrup-
tion treated with SPIONs with/without antimicrobials. (B) Anti-biofilm
efficiency of IOPs. Laser scanning confocal microscopy images for LIVE
(green)/DEAD (red) staining of biofilms under different treatments for
24 h (1 × stock = 100 mg mL−1 SPION; 50 mg mL−1 methicillin). (a) Living
and dead bacteria in the boundary of the external applied magnetic field
for different treatments from tile scans collected halfway across the
biofilm. (b) 3D reconstructions of z-stacks collected across the biofilm
thickness inside the magnetic field. Reprinted with permission from ref.
44. Copyright Elsevier 2017.
Minireview Nanoscale














































activities, such as enzyme-like activities of peroxidase, oxidase,
DNase, and haloperoxidase, of nanozymes can cause irrevers-
ible damage to bacteria/biofilms. These nanozymes as anti-
microbial agents have a host of advantages including low cost,
high stability, easy functionalization, and other attractive
optical, electronic, and magnetic properties. However, there
are still several problems that need to be addressed for the
further development of nanozymes and their antimicrobial
applications.
(1) Although nanozymes can overcome some shortcomings
of natural enzymes, their catalytic activities cannot keep up
with that of the natural enzymes. Moreover, nanozymes
usually have a low binding affinity for the substrate. Therefore,
the exploration of highly efficient nanozymes with excellent
substrate affinity is urgently needed. An effective way is to
further optimize their size, morphology, component as well as
surface modification. For instance, through surface
functionalization,70 we can mimic the surface microenvi-
ronment of the natural enzymes and thus obtain better affinity
towards the substrates. Alternatively, the design of novel nano-
zymes provides an additional way to construct highly efficient
antimicrobial agents. To date, the focus has been on redox
nanozymes. The introduction of new nanozymes, especially
new types of nanozymes (e.g., proteolytic enzyme), might
provide unexpected antimicrobial activities.
(2) Although nanomaterials possess many attractive optical,
electronic, and magnetic properties, these properties have not
been utilized. By integrating these special physicochemical
properties, unique systems may be constructed.
(3) Previous studies have shown that many nanomaterials
can simultaneously possess multi-enzyme-like properties;
however, whether these enzymatic activities will interfere with
each other is unclear. For instance, gold nanoparticles have
peroxidase, superoxide dismutase and catalase mimicking
activities. The presence of the superoxide dismutase- and cata-
lase-like activities might affect the overall antimicrobial per-
formance of nanomaterials.71,72 Therefore, researchers need to
pay more attention to these issues.
(4) Plenty of nanozymes have been discovered to have the
capability of killing bacteria and inhibiting biofilm formation.
However, the detailed mechanisms are still unclear.
(5) For exploring the practical applications of nanozymes
in vivo, the long-term biosafety of nanozymes should be con-
sidered in the future as most of the toxicity examinations
reported to date have been performed on mice for a short
period of time. Moreover, whether a hidden safety risk exists
should be paid more attention to in the future.
Due to the rapid advancement in nanotechnology and the
enormous achievements in bio- and biomimetic applications,
we expect that this active research area will continue to thrive
and mature in the future.
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